Prevention and treatment of osteoporosis in women

The British Menopause Society Council aims to aid health professionals to inform and advise women about post reproductive health. Osteoporosis affects one in three women. This guidance regarding estrogen and non-estrogen-based treatments for osteoporosis responds to the controversies about the benefits and risks of individual agents. Treatment choice should be based on up-to-date evidence-based information and targeted to individual women’s needs